Your browser doesn't support javascript.
loading
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Jiang, Honglin; Courau, Tristan; Borison, Joseph; Ritchie, Alexa J; Mayer, Aaron T; Krummel, Matthew F; Collisson, Eric A.
Affiliation
  • Jiang H; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Courau T; Department of Pathology, University of California San Francisco, San Francisco, California; ImmunoX Initiative, University of California San Francisco, San Francisco, California.
  • Borison J; Enable Medicine, Menlo Park, California.
  • Ritchie AJ; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Mayer AT; Enable Medicine, Menlo Park, California.
  • Krummel MF; Department of Pathology, University of California San Francisco, San Francisco, California; ImmunoX Initiative, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Collisson EA; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. Electronic address: collissonlab@gmail.com.
Gastroenterology ; 162(2): 590-603.e14, 2022 02.
Article in En | MEDLINE | ID: mdl-34627860
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Piperidines / Autophagy / Azetidines / Mefloquine / CD40 Antigens / Carcinoma, Pancreatic Ductal / Protein Kinase Inhibitors / Tumor Microenvironment / Tumor-Associated Macrophages Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Piperidines / Autophagy / Azetidines / Mefloquine / CD40 Antigens / Carcinoma, Pancreatic Ductal / Protein Kinase Inhibitors / Tumor Microenvironment / Tumor-Associated Macrophages Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article